@article{CJCR2530,
author = {Yiyao Xu and Xin Lu and Yilei Mao and Xinting Sang and Haitao Zhao and Shunda Du and Haifeng Xu and Yongliang Sun and Huayu Yang and Tianyi Chi and Zhiying Yang and Shouxian Zhong and Jiefu Huang},
title = {Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions},
journal = {Chinese Journal of Cancer Research},
volume = {25},
number = {4},
year = {2013},
keywords = {},
abstract = {Objective: We examined 103 cases over the last five years and discussed diagnosis and treatment of alphafetoprotein (AFP)-negative small hepatic lesions.
Background: Small hepatic lesions (less than 2 cm in diameter) usually have no typical imaging characteristics and therefore are difficult to diagnose, especially when AFP tests provide a negative result.
Methods: A total of 103 patients with AFP-negative small hepatic lesions from January 2003 to December 2008 were retrospectively reviewed. Differential diagnosis was performed by digital subtraction angiography (DSA), dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), contrast-enhanced ultrasound (CEUS), or positron emission tomography-computed tomography (PET-CT) based on the multiplicity of lesions. Ninety-four patients with suspected cancers underwent partial hepatectomy. Clinical data were collected from hospital records and follow-up questionnaires.
Results: Hepatocellular carcinoma (HCC) diagnostic sensitivity of DSA, DCE-MRI, CEUS and PET-CT was 88.2%, 93.9%, 88.9% and 88.9%, respectively. The surgery-related complication rate was 6.4%. Prognosis was good, with 1- and 3-year survival rates of 98.8% and 76.1%, respectively.
Conclusions: DSA, DCE-MRI, CEUS and PET-CT are valuable for diagnosis of small hepatic lesions. Partial hepatectomy is a preferred surgical procedure. Surgery for small liver cancers usually has little risk and good prognosis, therefore it can be actively applied in suspected HCC cases.},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/2530}
}